Where is AbbVie Inc. (ABBV) Headed According to the Street?

AbbVie Inc. (NYSE:ABBV) is 1 of the champion aesculapian probe stocks to bargain according to hedge funds. AbbVie Inc. (NYSE:ABBV) received standing updates from Guggenheim and UBS connected February 5, with Guggenheim reaffirming a Buy standing connected the banal with a $242 terms people and UBS revising the terms people to $230 from $240 portion keeping a Neutral standing connected the shares.

Evercore ISI besides adjusted the terms people connected AbbVie Inc. (NYSE:ABBV) connected February 4, maintaining an Outperform standing connected the banal and lowering the terms people to $228 from $232. The steadfast told investors successful a probe enactment that contempt Tremfya intelligibly taking share, the 2026 guidance/consensus inactive looks beatable, aforesaid with 2027. It further stated that it is “worth noting” that the buy-side has been supra statement for a while, and the borderline beats look smaller, adding that the existent complication is 2028+ growth, particularly with much caller entrants coming online.

The standing updates came aft AbbVie Inc. (NYSE:ABBV) reported its fiscal Q4 and full-year 2025 results connected February 4, delivering full-year nett revenues of $61.160 billion, up 8.6% connected a reported ground and up 8.5% connected an operational basis. The institution further reported full-year diluted EPS of $2.36 connected a GAAP basis, reflecting a alteration of 1.3%, and an adjusted diluted EPS of $10.00, down 1.2%. Management reported that the results included an unfavorable interaction of $2.76 per stock related to the 2025 acquired IPR&D and milestones expense.

AbbVie Inc. (NYSE:ABBV) is simply a research-based pharmaceutical institution that develops and sells products to dainty chronic diseases successful oncology, gastroenterology, rheumatology, dermatology, virology, and assorted different superior wellness conditions.

While we admit the imaginable of ABBV arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.